A series of live, online Virtual Symposia offers the opportunity for physicians, nurse practitioners, physician assistants, and other healthcare providers to gather to learn about current issues in primary care and to interact with one another for engaging discussions and collaborative learning.
Live virtual symposia dates:
Learn about the appropriate use of GLP-1 RAs to address elevated A1C, obesity, and CV risk, as well as strategies to improve tolerability and adherence.
Access expert recommendations for GLP-1 receptor agonist therapy for patients with type 2 diabetes.
In my practice, I choose the most effective treatment across the board to control blood sugar and reduce the risk for complications from renal, cardiovascular, and other common comorbidities.
For patients with T2D and cardiovascular disease, we are fortunate to have several GLP-1 receptor agonists with an indication for reducing the risk of major adverse cardiovascular events. Here’s my approach to choosing among them.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.